Nurses and midwives take the lead in providing HIV services in Eastern and Southern Africa

July 08, 2020

July 8, 2020 - "Nurse-initiated and managed antiretroviral therapy" (NIMART) is an innovative approach to making effective medications more accessible to people living with HIV (PLWH) in low-resource countries. A new study identifies challenges and opportunities to promoting nurse- and midwife-led HIV services in eastern and southern Africa, reports the July/August issue of The Journal of the Association of Nurses in AIDS Care(JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Improved training, supportive supervision, and formal mentorship programs are key steps toward establishing or strengthening NIMART care, suggests the new research by Rebecca E. MacKay, MPH, of Rollins School of Public Health at Emory University, Atlanta, and colleagues. They write, "Health facilities have important opportunities to advance NIMART practice through strengthening these aspects of in-service support."

Nurses/ Midwives Need Support and Education to Meet NIMART Goals

Eastern and southern Africa accounts for more than half of the PLWH globally - however, the region has also shown remarkable progress toward eliminating HIV. From 2010 to 2018, new HIV/AIDS cases declined by 28 percent in eastern and southern Africa, compared to a global decline of 16 percent.

Increasing access to effective antiretroviral therapy (ART) is a major part of the Fast-Track Strategy of the Joint United Nations Program on HIV/AIDS (UNAIDS), which aims to end the AIDS epidemic by 2030. Designed to make ART more accessible, NIMART is a "task-sharing" approach that enables nurses, midwives, and nurse-midwives - professionals who are far more available than physicians in sub-Saharan African - to provide advanced clinical services, including HIV testing and prescribing of ART for PLWH.

The study included a questionnaire completed by 200 nurses, midwives, and nurse-midwives at 30 healthcare facilities in 11 eastern and southern African countries. Up to 80 percent of nurses/midwives responded that they had "sufficient authority" to provide NIMART care. Sixty percent or more agreed that their pre-service education and in-service training had effectively prepared them to offer HIV treatment.

However, the nurses/midwives expressed more concerns about their level of supervision and mentorship. More than one-third of respondents felt they did not receive adequate supportive supervision or feedback on care provided. Nurses, midwives, and nurse-midwives providing pediatric HIV care tended to have less-positive responses than those providing prevention of mother-to-child transmission services for pregnant and breastfeeding women or HIV-exposed infants.

Interviews with 62 clinical supervisors at the same facilities identified several barriers to effective NIMART care: deficiencies in training, staff shortages, inadequate supplies or space, high workloads, and challenges in managing children with HIV. But the supervisors interpreted many of these barriers and challenges as potential opportunities for improving NIMART services: strengthening in-service training, increasing staffing, providing adequate supplies and space, and increasing capacity for pediatric services.

In a triangulation step, the issues identified in the nurse/midwife questionnaires and supervisor interviews were consistent with each other. "Although the nurses, midwives, and nurse midwives in the facilities assessed clearly had the authority to provide NIMART services, a substantial proportion did not feel that they were well prepared or well supported to deliver this care," Ms. MacKay and coauthors write.

The researchers believe their findings have implications for efforts to promote effective provision of NIMART care in southern and eastern Africa. Steps facilities can take to improve NIMART services include standardized in-service training, formal clinical mentorship programs in prevention, and specific protocols for ongoing supportive supervision. Ms. MacKay and colleagues conclude: "Taking advantage of these opportunities may be a critically important step toward meeting the Fast Track Strategy to the AIDS epidemic by 2030."
-end-


Click here to read "Nurse- and Midwife-Led HIV Services in Eastern and Southern Africa: Challenges and Opportunities for Health Facilities."


DOI: 10.1097/JNC.0000000000000176

About JANACThe Journal of the Association of Nurses in AIDS Care(JANAC) is a peer-reviewed, international nursing journal that covers the full spectrum of the global HIV epidemic, focusing on prevention, evidence-based care management, interprofessional clinical care, research, advocacy, policy, education, social determinants of health, epidemiology, and program development. JANAC functions according to the highest standards of ethical publishing practices and offers innovative publication options, including Open Access and prepublication article posting, where the journal can post articles before they are published with an issue.

About the Association of Nurses in AIDS Care

Since 1987, the Association of Nurses in AIDS Care (ANAC) has been the leading nursing organization responding to HIV/AIDS. The mission of ANAC is to foster the professional development of nurses and others involved in the delivery of healthcare for persons at risk for, living with, and/or affected by the human immunodeficiency virus (HIV) and its co-morbidities. ANAC promotes the health, welfare and rights of people living with HIV around the world.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit http://www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Wolters Kluwer Health

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.